openPR Logo
Press release

Retinitis Pigmentosa Treatment Market Driven by Gene Therapy Progress and Increased Research Funding 2025-2033 | Spark Therapeutics, Inc., jCyte, Inc., Coave Therapeutics, Kiora Pharmaceuticals, Inc.

07-16-2025 01:26 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Retinitis Pigmentosa Treatment Market

Retinitis Pigmentosa Treatment Market

Retinitis Pigmentosa Treatment Market size reached US$ 5.72 Billion in 2024 and is expected to reach US$ 11.13 Billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033.

Retinitis Pigmentosa Treatment Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With a focus on emerging drug technologies, evolving treatment paradigms, and regulatory frameworks, the report delivers strategic insights to support stakeholders in navigating the rapidly advancing sector from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/retinitis-pigmentosa-treatment-market?ophp

Retinitis pigmentosa is a group of inherited retinal disorders causing progressive vision loss due to photoreceptor degeneration. The treatment market is expanding with the emergence of gene therapies, retinal implants, and neuroprotective agents, alongside rising investment in precision ophthalmology for rare genetic eye diseases.

Retinitis Pigmentosa Treatment Market Competitors Overview:

Spark Therapeutics, Inc., jCyte, Inc., Coave Therapeutics, Kiora Pharmaceuticals, Inc., Aldeyra Therapeutics, Inc., Beacon Therapeutics, ViGeneron GmbH, Nanoscope Therapeutics Inc., SparingVision, Inc., and Endogena Therapeutics Inc., among others.

Important Industry Updates of 2023, 2024 and 2025:

✅ In January 2025, ViGeneron GmbH, a next-generation clinical-stage gene therapy company, announced two important milestones for its novel gene therapy candidate VG901, to treat patients with retinitis pigmentosa (RP) caused by mutations in the CNGA1 gene. The U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to VG901, and the independent Data Safety Monitoring Board (DSMB) has unanimously approved dose escalation in the ongoing Phase 1b clinical trial.

✅ In August 2024, Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Health Canada provided a "No Objection Letter" to initiate the OCU400 Phase III liMeliGhT clinical trial in Canada. OCU400 is a modifier gene therapy product candidate being developed for retinitis pigmentosa (RP).

Methodology and Scope

The Retinitis Pigmentosa Treatment Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/retinitis-pigmentosa-treatment-market?ophp

Retinitis Pigmentosa Treatment Market Segments Overview:

∎ By Disease Type(Non-Syndromic Retinitis Pigmentosa, Syndromic Retinitis Pigmentosa)
∎ By Treatment Type (Gene Therapy, Vision Rehabilitation, Sunglasses, Vitamin A Supplements, Omega-3 Fatty Acids, Surgery, Others)

Regional Overview for Retinitis Pigmentosa Treatment Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=retinitis-pigmentosa-treatment-market?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the «Keyword» market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the «Keyword» market?

Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Retinitis Pigmentosa Treatment Market Driven by Gene Therapy Progress and Increased Research Funding 2025-2033 | Spark Therapeutics, Inc., jCyte, Inc., Coave Therapeutics, Kiora Pharmaceuticals, Inc. here

News-ID: 4106395 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Semiconductor Packaging Market Soars with 7.2% CAGR as 3D, Hybrid Bonding Innovations Power AI, 5G, and Automotive Tech
Semiconductor Packaging Market Soars with 7.2% CAGR as 3D, Hybrid Bonding Innova …
The global semiconductor packaging market is on a growth trajectory driven by demand for advanced chip integration, AI-enabled devices, electric vehicles, and compact consumer electronics. The market is projected to grow at a robust CAGR of 7.2% from 2024 to 2031. Technological innovations in 3D packaging, fan-out wafer-level packaging (FO-WLP), and hybrid bonding are reshaping packaging architectures, while geopolitical shifts and supply chain strategies are fueling regional investment. Request your
Wood Fuels Market Report 2025: Drive Growth with Smart, Eco-Friendly Energy Alternatives | Top key players- AS Graanul Invest,Drax Group PLC,Lignetics Inc.
Wood Fuels Market Report 2025: Drive Growth with Smart, Eco-Friendly Energy Alte …
Global Wood Fuels Market was valued at $15,519.33 million in 2024 and is estimated to grow to $25,305.73 million in 2031. The Wood Fuels Market is growing at a CAGR of 10.27% during 2024-2031, primarily due to the rising demand for renewable and sustainable energy sources. Increasing concerns over carbon emissions, supportive government policies promoting bioenergy, and the cost-effectiveness of wood fuels compared to fossil fuels are driving market expansion.
Automotive Cybersecurity Market: Projected to Surge to $13.87 Billion by 2031 as Innovators Like Bosch & Continental Unlock Growth Opportunities in the Era of Smart Vehicles
Automotive Cybersecurity Market: Projected to Surge to $13.87 Billion by 2031 as …
The automotive cybersecurity market is projected to grow from USD 4.55 billion in 2024 to around USD 13.87 billion by 2031, reflecting a robust CAGR of 16.5% during the forecast period (2024-2031). The Automotive Cybersecurity Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their
Mexico High Performance Polymers Market Accelerates with Eco-Friendly & Durable Solutions | Top key players- DuPont de Nemours México, S.A. de C.V., Toray Resin Mexico, S.A. de C.V., Alpek, S.A.B. de C.V., and Orbia Advance Corporation, S.A.B. de C.V.
Mexico High Performance Polymers Market Accelerates with Eco-Friendly & Durable …
Mexico high-performance polymers Market reached US$ 880.12 million in 2024 and is expected to reach US$ 1,297.37 million by 2032, growing at a CAGR of 4.97% during the forecast period of 2025-2032. The Mexico High Performance Polymers Market is growing at a CAGR of 4.97% during 2024-2031 due to rising demand from key industries such as automotive, aerospace, electronics, and healthcare. These polymers offer superior properties like high thermal stability,

All 5 Releases


More Releases for Retinitis

Shaping the Retinitis Pigmentosa Market in 2025: Innovative Gene Therapy Develop …
How Big Is the Retinitis Pigmentosa Market Expected to Be, and What Will Its Growth Rate Be? In recent times, a significant expansion has been witnessed in the market size of retinitis pigmentosa. The market is set to rise from $11.32 billion in 2024 to $12.22 billion in 2025, delivering a compound annual growth rate (CAGR) of 8.0%. The proliferation in the preceding period is due to progress in genetic
Shaping the Retinitis Pigmentosa Market in 2025: Innovative Gene Therapy Develop …
How Big Is the Retinitis Pigmentosa Market Expected to Be, and What Will Its Growth Rate Be? In recent times, a significant expansion has been witnessed in the market size of retinitis pigmentosa. The market is set to rise from $11.32 billion in 2024 to $12.22 billion in 2025, delivering a compound annual growth rate (CAGR) of 8.0%. The proliferation in the preceding period is due to progress in genetic
Retinitis Pigmentosa Market Growth and Treatment Advancements
The retinitis pigmentosa (RP) market has garnered considerable attention in recent years due to its profound impact on individuals' lives. As one of the leading causes of hereditary blindness, RP is a genetic eye disorder that progressively leads to vision loss. The market for retinitis pigmentosa treatments was valued at USD 14.02 billion in 2023, and with significant advancements on the horizon, it is expected to reach USD 21.40 billion
Retinitis Pigmentosa Market Research and Market Share Insights
The Business Research Company recently released a comprehensive report on the Global Retinitis Pigmentosa Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Cytomegalovirus Retinitis Market Forecast 2031: Growth and Opportunities
The "Cytomegalovirus Retinitis Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats, alongside
Retinitis Pigmentosa (Retinitis) Market Analysis and Future Prospects for 2030
The world of the retinitis pigmentosa (retinitis) market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing